p53 prevents immature escaping from cell cycle G2 checkpoint arrest through inhibiting cdk2-dependent NF-Y

Un-Jung Yun1, Heui-Dong Park, Deug Y Shin

  • 1National Research Laboratory of Cell Cycle Regulation, Department of Microbiology, Dankook University College of Medicine, Cheonan, Korea.

Abstract

Insights

The tumor suppressor p53 prevents premature cell cycle G2 arrest escape via p21, maintaining genomic stability. p53 deficiency leads to early mitosis entry and cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • p53 is a critical tumor suppressor involved in cell cycle regulation and genomic integrity.
  • The G2 checkpoint prevents entry into mitosis until DNA damage is repaired.

Purpose of the Study:

  • To investigate the role of p53 in escaping cell cycle G2 arrest following DNA damage.
  • To understand how p53 influences genomic stability maintenance.

Main Methods:

  • Utilized human colon cancer cell lines (HCT116) with p53 or p21 deletions.
  • Employed FACS analysis, immunoprecipitation, Western blot, and IP-kinase assays to examine cell cycle arrest.
  • Assessed kinase activity and gene expression related to the G2 checkpoint.

Main Results:

  • p53-deficient cells showed impaired G1 arrest but G2 arrest, yet failed to sustain G2 arrest, entering mitosis prematurely.
  • Reactivation of Cdc2 kinase occurred in p53-deficient cells during mitosis entry.
  • p21-deficient cells exhibited reduced repression of NF-Y phosphorylation and G2-regulatory gene expression (cdc2, cyclin B, RNR-R2, cdc25C).

Conclusions:

  • p53 is crucial for preventing premature G2 arrest escape through p21-mediated Cdk2 inactivation.
  • This p53-dependent pathway inhibits NF-Y phosphorylation and the transcription of key G2-regulatory genes.
  • Dysregulation of this pathway in p53-deficient cells contributes to genomic instability and cell death.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...